The Japanese Society of Hypertension (JSH) revised the Guidelines for the Management of
Hypertension 2014 (JSH 2014), and published the JSH 2019. In the development of the JSH …

Human abdominal aortic aneurysm (AAA) pathophysiology is not yet completely understood.
In conductance arteries, the insoluble extracellular matrix, synthesized by vascular smooth …

Background The association between type 1 diabetes mellitus (T1DM) and specific
cardiovascular diseases (CVD) is uncertain. Furthermore, data on type 2 diabetes mellitus …

Importance Abdominal aortic aneurysms affect more than 3% of US older adults. Objective
To test whether doxycycline reduces the growth of abdominal aortic aneurysm over 2 years …

Background There are no recognized pharmacological treatments for abdominal aortic
aneurysms (AAA), although statins are suggested to be beneficial. We sought to summarize …

Background No studies have examined long‐term risks for aortic aneurysm (AA) and aortic
dissection (AD) or mortality after AA or AD hospitalization among patients with type 2 …

Aims Abdominal aortic aneurysm is a life-threatening condition due to the risk of aneurysm
growth and rupture. There are no approved diagnostic or prognostic biomarkers for …

Epidemiological data positively correlate plasma serum amyloid A (SAA) levels with
cardiovascular disease severity and mortality. Studies by several investigators have …

Background Abdominal aortic aneurysms (AAA) rupture can lead to patient death. Surgical
treatment is currently the optimal treatment for AAA with large diameter (≥ 50 mm). For AAA …

Objective The necessity and efficacy of statin treatment for abdominal aortic aneurysm (AAA)
remains controversial. This systematic review and meta-analysis was conducted to …